Archive - February 2018
Novo’s oral semaglutide ‘safe and well-tolerated’
New research looks to reduce side effects in commonly used drugs
Virginia governor voices optimism for state Medicaid expansion
Last of the Molinas: Former CFO resigns from insurer’s board
Edward-Elmhurst Health plans another round of cuts
Pfizer’s leukaemia drug Mylotarg backed for use in EU
CHMP backs AZ’s Lynparza for ovarian cancer maintenance
EU clears rare musculoskeletal disorder drug